Dr. Marianna Fontana, primary investigator of HELIOS-B, discusses the full study results presented at the European Society of Cardiology Congress

She describes the study results, offers her opinion on where vutrisiran may enter the treatment paradigm, and shares more about ATTR-CM such as the difference between men and women in these studies.